Lisbeth Illum

25.4k total citations · 9 hit papers
220 papers, 20.2k citations indexed

About

Lisbeth Illum is a scholar working on Pharmaceutical Science, Biomaterials and Molecular Biology. According to data from OpenAlex, Lisbeth Illum has authored 220 papers receiving a total of 20.2k indexed citations (citations by other indexed papers that have themselves been cited), including 115 papers in Pharmaceutical Science, 58 papers in Biomaterials and 54 papers in Molecular Biology. Recurrent topics in Lisbeth Illum's work include Advanced Drug Delivery Systems (107 papers), Nanoparticle-Based Drug Delivery (46 papers) and Drug Solubulity and Delivery Systems (37 papers). Lisbeth Illum is often cited by papers focused on Advanced Drug Delivery Systems (107 papers), Nanoparticle-Based Drug Delivery (46 papers) and Drug Solubulity and Delivery Systems (37 papers). Lisbeth Illum collaborates with scholars based in United Kingdom, Denmark and Italy. Lisbeth Illum's co-authors include S.S. Davis, Snow Stolnik, Stanley S. Davis, Stanley S. Davis, Luca Casettari, S.S. Davis, Nidal F. Farraj, Inderjit Jabbal‐Gill, Martin C. Garnett and S.S. Davis and has published in prestigious journals such as Biomaterials, Advanced Functional Materials and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Lisbeth Illum

219 papers receiving 19.1k citations

Hit Papers

Nasal drug delivery—possi... 1994 2026 2004 2015 2003 2000 1994 1995 2001 250 500 750

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Lisbeth Illum 10.0k 6.3k 5.9k 2.3k 2.2k 220 20.2k
Marı́a José Alonso 12.3k 1.2× 8.5k 1.3× 8.3k 1.4× 3.0k 1.3× 1.9k 0.8× 299 24.1k
Hans E. Junginger 10.9k 1.1× 3.1k 0.5× 4.7k 0.8× 1.1k 0.5× 1.7k 0.7× 233 17.6k
Andreas Bernkop‐Schnürch 15.5k 1.5× 6.5k 1.0× 6.7k 1.1× 1.9k 0.8× 2.8k 1.3× 567 24.9k
Claus‐Michael Lehr 8.9k 0.9× 4.3k 0.7× 6.1k 1.0× 3.5k 1.5× 1.3k 0.6× 417 22.0k
Thomas Kissel 5.8k 0.6× 8.6k 1.4× 12.8k 2.2× 4.5k 2.0× 2.8k 1.3× 309 26.8k
Robert Gurny 9.4k 0.9× 8.4k 1.3× 4.4k 0.7× 5.6k 2.4× 2.3k 1.0× 334 25.3k
Justin Hanes 8.1k 0.8× 6.2k 1.0× 8.4k 1.4× 4.9k 2.1× 1.1k 0.5× 217 24.2k
Bruno Sarmento 8.4k 0.8× 5.8k 0.9× 6.0k 1.0× 4.2k 1.8× 1.2k 0.5× 485 22.5k
Hatem Fessi 5.7k 0.6× 5.6k 0.9× 3.4k 0.6× 3.4k 1.5× 2.1k 0.9× 216 15.8k
Véronique Préat 7.3k 0.7× 8.7k 1.4× 8.3k 1.4× 6.7k 2.9× 1.3k 0.6× 312 25.2k

Countries citing papers authored by Lisbeth Illum

Since Specialization
Citations

This map shows the geographic impact of Lisbeth Illum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lisbeth Illum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lisbeth Illum more than expected).

Fields of papers citing papers by Lisbeth Illum

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lisbeth Illum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lisbeth Illum. The network helps show where Lisbeth Illum may publish in the future.

Co-authorship network of co-authors of Lisbeth Illum

This figure shows the co-authorship network connecting the top 25 collaborators of Lisbeth Illum. A scholar is included among the top collaborators of Lisbeth Illum based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lisbeth Illum. Lisbeth Illum is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Touítou, Elka & Lisbeth Illum. (2012). Nasal drug delivery. Drug Delivery and Translational Research. 3(1). 1–3. 67 indexed citations
2.
Stolnik, Snow, et al.. (2009). Nanoparticles for direct nose-to-brain delivery of drugs. International Journal of Pharmaceutics. 379(1). 146–157. 550 indexed citations breakdown →
3.
Illum, Lisbeth. (2006). Nasal Clearance in Health and Disease. Journal of Aerosol Medicine. 19(1). 92–99. 34 indexed citations
4.
Stolnik, Snow, Albertina Ariën, C. R. Heald, et al.. (2001). The effect of surface coverage and conformation of poly(ethylene oxide) (PEO) chains of poloxamer 407 on the biological fate of model colloidal drug carriers. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1514(2). 261–279. 117 indexed citations
5.
Carney, A. Simon, Nicholas S. Jones, M. Frier, et al.. (2001). The effect of the nasal cycle on mucociliary clearance. Clinical Otolaryngology. 26(1). 9–15. 41 indexed citations
6.
McGurk, Simon L., Giles H.W. Sanders, Martyn C. Davies, et al.. (2000). A High Resolution Atomic Force Microscopy Study of Poly(lactic acid-co-ethylene glycol). Polymer Journal. 32(5). 444–446. 1 indexed citations
7.
Jabbal‐Gill, Inderjit, Lin Wu, Peter Watts, et al.. (1999). Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines. Vaccine. 18(3-4). 238–250. 41 indexed citations
8.
Scholes, Peter, A.G.A. Coombes, Lisbeth Illum, et al.. (1999). Detection and determination of surface levels of poloxamer and PVA surfactant on biodegradable nanospheres using SSIMS and XPS. Journal of Controlled Release. 59(3). 261–278. 118 indexed citations
9.
Illum, Lisbeth, et al.. (1997). Preparation of Biodegradable, Surface Engineered PLGA Nanospheres with Enhanced Lymphatic Drainage and Lymph Node Uptake. Pharmaceutical Research. 14(5). 657–661. 91 indexed citations
10.
Illum, Lisbeth, et al.. (1994). Cyclodextrins as protection agents against enhancer damage in nasal delivery systems I. Assessment of effect by measurement of erythrocyte haemolysis. European Journal of Pharmaceutical Sciences. 1(5). 229–236. 20 indexed citations
11.
Thomas, Norman W., et al.. (1994). Nasal Absorption in the Rat. III. Effect of Lysophospholipids on Insulin Absorption and Nasal Histology. Pharmaceutical Research. 11(11). 1623–1630. 29 indexed citations
12.
Moghimi, S. Moein, et al.. (1994). Surface engineered nanospheres with enhanced drainage into lymphatics and uptake by macrophages of the regional lymph nodes. FEBS Letters. 344(1). 25–30. 117 indexed citations
13.
Stolnik, Snow, Susan E. Dunn, Martin C. Garnett, et al.. (1994). Surface Modification of Poly(lactide-co-glycolide) Nanospheres by Biodegradable Poly(lactide)-Poly(ethylene glycol) Copolymers. Pharmaceutical Research. 11(12). 1800–1808. 242 indexed citations
14.
Wu, Lin, Allan G.A. Coombes, Martin C. Garnett, et al.. (1994). Preparation of Sterically Stabilized Human Serum Albumin Nanospheres Using a Novel Dextranox-MPEG Crosslinking Agent. Pharmaceutical Research. 11(11). 1588–1592. 39 indexed citations
15.
Artursson, Per, Tuulikki Lindmark, Stanley S. Davis, & Lisbeth Illum. (1994). Effect of Chitosan on the Permeability of Monolayers of Intestinal Epithelial Cells (Caco-2). Pharmaceutical Research. 11(9). 1358–1361. 636 indexed citations breakdown →
16.
Illum, Lisbeth & Stanley S. Davis. (1992). Intranasal Insulin. Clinical Pharmacokinetics. 23(1). 30–41. 29 indexed citations
17.
Torrado, Juan J., Lisbeth Illum, & S.M. Davis. (1989). Particle size and size distribution of albumin microspheres produced by heat and chemical stabilization. International Journal of Pharmaceutics. 51(1). 85–93. 52 indexed citations
18.
Illum, Lisbeth & Stanley S. Davis. (1987). Polymers in controlled drug delivery. 193 indexed citations
19.
Illum, Lisbeth, et al.. (1985). Recent advances in the use of microspheres for targeted therapy.. PubMed. 11(9). 633–40. 26 indexed citations
20.
Illum, Lisbeth & Philip Jones. (1985). [6] Attachment of monoclonal antibodies to microspheres. Methods in enzymology on CD-ROM/Methods in enzymology. 112. 67–84. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026